Evidence map›Paper›PMID 26101850›Full record

ReviewTranslational psychiatry2015

Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.

J Smucny, K E Stevens, A Olincy, J R Tregellas

Abstract readReview
In one paragraph

Review in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Selective 5HT3 antagonists and sensory processing: a systematic review.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Cholinergic modulation of sensory perception and plasticity.Neuroscience and biobehavioral reviews · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J Smucny1] Neuroscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA [2] Research Service, Denver VA Medical Center, Denver, CO, USA [3] Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
K E StevensDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
A Olincy1] Research Service, Denver VA Medical Center, Denver, CO, USA [2] Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
J R Tregellas1] Neuroscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA [2] Research Service, Denver VA Medical Center, Denver, CO, USA [3] Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Funding

STATISTICAL GENETICS AND TREATMENT ANALYSISP50MH086383 · NIMH · UNIVERSITY OF COLORADO DENVER · PI FREEDMAN, ROBERT R · 2009 to 2013
$10.6M
Functional Imaging of the Nicotinic Basis for Attention Deficits in SchizophreniaF31MH102879 · NIMH · UNIVERSITY OF COLORADO DENVER · PI SMUCNY, JASON · 2014 to 2016
$76k
NIMH NIH HHS 1F31-MH102879-01A1NIMH NIH HHS F31 MH102879NIMH NIH HHS MH-086383-01NIMH NIH HHS P50 MH086383
6 · The paper itself

Abstract

Impaired gating of the auditory evoked P50 potential is one of the most pharmacologically well-characterized features of schizophrenia. This deficit is most commonly modeled in rodents by implanted electrode recordings from the hippocampus of the rodent analog of the P50, the P20-N40. The validity and effectiveness of this tool, however, has not been systematically reviewed. Here, we summarize findings from studies that have examined the effects of pharmacologic modulation on gating of the rodent hippocampal P20-N40 and the human P50. We show that drug effects on the P20-N40 are highly predictive of human effects across similar dose ranges. Furthermore, mental status (for example, anesthetized vs alert) does not appear to diminish the predictive capacity of these recordings. We then discuss hypothesized neuropharmacologic mechanisms that may underlie gating effects for each drug studied. Overall, this review supports continued use of hippocampal P20-N40 gating as a translational tool for schizophrenia research.

Indexed as

AnimalsCholinergic AgentsDisease Models, AnimalEvoked Potentials, AuditoryHippocampusMiceRatsSchizophreniaSensory GatingTranslational Research, BiomedicalCholinergic Agents

Identifiers

PMID26101850
PMCPMC4490287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.